The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ’s free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices